Rajendra S. Apte
9Patents
1h-index
2Co-inventors
37Inventor score
Filing activity: Jun 14, 2013 → Sep 21, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9844561B2 | Administration of nicotinamide mononucleotide in the treatment of disease | Human Necessities | 1 | Active |
| US11137408B2 | GDF15 in glaucoma and methods of use thereof | Physics | 1 | Active |
| US9399045B2 | Inhibition of choroidal neovascularization | Chemistry; Metallurgy | 0 | Active |
| US10925888B2 | Administration of nicotinamide mononucleotide in the treatment of disease | Human Necessities | 0 | Active |
| US9121019B2 | Inhibition of choroidal neovascularization | Chemistry; Metallurgy | 0 | Active |
| US9254285B2 | Inhibition of choroidal neovascularization | Chemistry; Metallurgy | 0 | Active |
| US11793824B2 | Administration of nicotinamide mononucleotide in the treatment of disease | Human Necessities | 0 | Active |
| US12150950B2 | Administration of nicotinamide mononucleotide in the treatment of disease | Human Necessities | 0 | Active |
| US11933791B2 | GDF15 in glaucoma and methods of use thereof | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.